Impact of CYP2C19 Metabolizer Status on Patients With ACS Treated With Prasugrel Versus Clopidogrel

Abstract Background Certain alleles of the CYP2C19 gene are associated with higher platelet reactivity and increased ischemic events among patients treated with clopidogrel. However, the relationship of CYP2C19 genotype and outcomes in medically managed patients with acute coronary syndromes (ACS) i...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the American College of Cardiology 2016-03, Vol.67 (8), p.936-947
Hauptverfasser: Doll, Jacob A., MD, Neely, Megan L., PhD, Roe, Matthew T., MD, MHS, Armstrong, Paul W., MD, White, Harvey D., MB, ChB, DSc, Prabhakaran, Dorairaj, MD, DM, MSc, Winters, Kenneth J., MD, Duvvuru, Suman, PhD, Sundseth, Scott S., PhD, Jakubowski, Joseph A., PhD, Gurbel, Paul A., MD, Bhatt, Deepak L., MD, MPH, Ohman, E. Magnus, MD, Fox, Keith A.A., MB, ChB
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!